IGF-1 L3 - ZPHC

As a modified form of IGF-1, Long(R3)-IGF-1 delivers more potent effects due to its structural alterations, providing muscle growth support without needing binding proteins. However, users should be cautious of hypoglycemia, a risk when using IGF-1 analogs. Following dosage guidelines and tapering up the amount helps users adapt and minimize blood sugar-related side effects, while carbohydrate intake shortly after injection is advised​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about IGF-1 L3 by ZPHC, consult with your doctor or healthcare professional.